# Mathias Wilkne

> Mathias Wilkne is a seed investor backing CRM, SaaS and Health Care. See 2 investments, round sizes, portfolio and contact details. Updated Nov 2026.

- Type: Angel Investor
- Total investments: 2
- Lead investor: 50%
- Last updated: Nov 2026
- LinkedIn: https://www.linkedin.com/in/mathias-wilkne-b53350111

Mathias Wilkne is a seed investor focused on CRM and SaaS. Mathias Wilkne

## Contacts

5 contacts available for Mathias Wilkne: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/mathias-wilkne?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| CRM | 1 | 50% |
| SaaS | 1 | 50% |
| Health Care | 1 | 50% |
| Sales Automation | 1 | 50% |
| Sales Enablement | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MediCheck | MediCheck is a multi-market service providing people with a shortcut to medical specialists online. People with chronic health conditions, and their relatives get expert medical advice based on individual preferences and requirements, using video calls or messaging. Their network of medical experts use our full-service platform to plan, perform anddocument the meetings. Customers pay the medical experts for service, MediCheck earns a commission. | $868K | Series A |  | http://medicheck.se/ |
| Flowmeets | Flowmeets provides an all-in-one AI-powered meeting intelligence platform that transforms how B2B sales teams handle performance tracking and administrative overhead. Featuring context-aware AI sales coaching, multi-language transcription, and smart scheduling links, we enable users to boost close rates by up to 20% and save up to 8 hours a weekon admin tasks without the traditional friction of privacy concerns or generic AI feedback. Built for seamless integration with existing CRMs and video tools—while maintaining strict, 100% GDPR and Schrems II compliant data sovereignty on EU serversWe are dedicated to optimizing the entire customer journey for modern sales organizations. | $300K | Seed |  | https://www.flowmeets.com/ |

2 of 2 investments shown.

## Similar investors

### Similar stage
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Mathias Wilkne invest in?

Mathias Wilkne invests primarily in CRM, SaaS and Health Care startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mathias Wilkne?

Public channels for Mathias Wilkne include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co